Atria Wealth Solutions, Inc. Amneal Pharmaceuticals, Inc. Transaction History

Atria Wealth Solutions, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 22, 2023	BUY	$1.27 - $2.7 $40,259 - $85,590	31,700 New	31,700 $44,000
Q1 2023 Jun 14, 2023	BUY	$1.27 - $2.7 $5,080 - $10,800	4,000 Added 12.62%	35,700 $49,000
Q1 2023 May 10, 2023	SELL	$1.27 - $2.7 $5,080 - $10,800	-4,000 Reduced 11.2%	31,700 $44,000
Q4 2022 Aug 30, 2023	BUY	$1.96 - $2.61 $69,972 - $93,177	35,700 New	35,700 $71,000
Q4 2022 Feb 13, 2023	SELL	$1.96 - $2.61 $2,940 - $3,915	-1,500 Reduced 4.03%	35,700 $71,000
Q3 2022 Nov 14, 2022	BUY	$2.02 - $3.62 $75,144 - $134,664	37,200 New	37,200 $75,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $54,179 - $80,280	-18,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.9 - $4.89 $70,200 - $88,020	18,000 New	18,000 $75,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.27B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.